Literature DB >> 9353136

Curcumin inhibition of Dermatophagoides farinea-induced interleukin-5 (IL-5) and granulocyte macrophage-colony stimulating factor (GM-CSF) production by lymphocytes from bronchial asthmatics.

T Kobayashi1, S Hashimoto, T Horie.   

Abstract

Curcumin, a dietary pigment responsible for the yellow color of curry, has been used for the treatment of inflammatory diseases and exhibits a variety of pharmacological effects such as anti-inflammatory, anti-tumor, anti-oxidant, and anti-viral activity. However, it has not been determined whether the effect of curcumin on the production of cytokine affects eosinophil functions and IgE synthesis. In the present study, we examined the effect of curcumin on the production of interleukin (IL)-2, IL-5, granulocyte macrophage-colony stimulating factor (GM-CSF), and IL-4 by lymphocytes from atopic asthmatics in response to house dust mites (Dermatophagoides farinea: Df) in order to clarify a potential application for allergic diseases. Curcumin inhibited Df-induced lymphocyte proliferation and production of IL-2. Exogenous IL-2 reconstituted the proliferative responsiveness of lymphocytes to Df in the presence of curcumin. Furthermore, curcumin inhibited IL-5, GM-CSF, and IL-4 production in a concentration-dependent manner. These results indicate that curcumin may have a potential effect on controlling allergic diseases through inhibiting the production of cytokines affecting eosinophil function and IgE synthesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9353136     DOI: 10.1016/s0006-2952(97)00220-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  13 in total

Review 1.  "Spicing up" of the immune system by curcumin.

Authors:  Ganesh Chandra Jagetia; Bharat B Aggarwal
Journal:  J Clin Immunol       Date:  2007-01-09       Impact factor: 8.317

Review 2.  The targets of curcumin.

Authors:  Hongyu Zhou; Christopher S Beevers; Shile Huang
Journal:  Curr Drug Targets       Date:  2011-03-01       Impact factor: 3.465

3.  The Effects of Curcumin in the Treatment of Gingivitis: A Systematic Review of Clinical Trials.

Authors:  Farinaz Shirban; Fateme Gharibpour; Ailin Ehteshami; Mohammad Bagherniya; Thozhukat Sathyapalan; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases.

Authors:  Bharat B Aggarwal; Kuzhuvelil B Harikumar
Journal:  Int J Biochem Cell Biol       Date:  2008-07-09       Impact factor: 5.085

Review 5.  Trials with 'epigenetic' drugs: an update.

Authors:  Angela Nebbioso; Vincenzo Carafa; Rosaria Benedetti; Lucia Altucci
Journal:  Mol Oncol       Date:  2012-10-06       Impact factor: 6.603

6.  Evaluation of Efficacy of Curcumin as an Add-on therapy in Patients of Bronchial Asthma.

Authors:  Afroz Abidi; Surabhi Gupta; Manu Agarwal; H L Bhalla; Mahip Saluja
Journal:  J Clin Diagn Res       Date:  2014-08-20

Review 7.  Curcumin: from ancient medicine to current clinical trials.

Authors:  H Hatcher; R Planalp; J Cho; F M Torti; S V Torti
Journal:  Cell Mol Life Sci       Date:  2008-06       Impact factor: 9.261

8.  Immune response modulation by curcumin in a latex allergy model.

Authors:  Viswanath P Kurup; Christy S Barrios; Raghavan Raju; Bryon D Johnson; Michael B Levy; Jordan N Fink
Journal:  Clin Mol Allergy       Date:  2007-01-25

Review 9.  Curcumin and Health.

Authors:  Mario Pulido-Moran; Jorge Moreno-Fernandez; Cesar Ramirez-Tortosa; Mcarmen Ramirez-Tortosa
Journal:  Molecules       Date:  2016-02-25       Impact factor: 4.411

10.  Oral curcumin supplementation in patients with atopic asthma.

Authors:  Dennis H Kim; Joshua F Phillips; Richard F Lockey
Journal:  Allergy Rhinol (Providence)       Date:  2011-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.